|
시장보고서
상품코드
2055161
뇌종양 치료 시장 : 치료법별, 종양 유형별, 약제 클래스별, 연령층별, 성별, 최종 사용자별, 유통 채널별, 지역별Brain Tumor Treatment Market, By Treatment Modality, By Tumor Type, By Drug Class, By Age Group, By Gender, By End User, By Distribution Channel, By Geography |
||||||
뇌종양 치료 시장은 2026년에 25억 8,000만 달러에 달하고 2033년까지 50억 5,000만 달러에 이를 전망입니다. 2026-2033년 CAGR은 10.1%를 나타낼 것으로 예측됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 25억 8,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 10.10% | 예측 금액(2033년) | 50억 5,000만 달러 |
세계 뇌종양 치료 시장은 광범위한 종양 치료 분야에서 매우 중요한 부분을 차지하고 있으며, 중추신경계에 영향을 미치는 가장 복잡하고 치료가 어려운 질환 중 하나를 다루고 있습니다.
뇌종양은 뇌 조직 내 또는 그 주변에서 비정상적인 세포 증식을 특징으로 하며, 뇌에서 발생한 원발성 종양과 다른 부위에서 전이된 이차성 종양을 모두 포함합니다. 치료 패러다임에는 외과적 개입, 방사선 치료, 화학요법, 표적 치료, 그리고 새로운 면역 요법 옵션을 결합한 다각적인 접근법이 포함되어 있으며, 각각은 특정 종양의 유형, 부위 및 환자의 상태에 맞추어 조정됩니다.
이 시장의 중요성은 기존의 치료법에 그치지 않고, 정위 방사선 수술, 종양 치료용 전기장, 분자 프로파일링에 기반한 맞춤형 의료 등 첨단 기술까지 포괄하고 있습니다. 전 세계 뇌종양 발병률 증가와 더불어 고령화 및 진단 능력의 향상으로 인해 효과적인 치료 솔루션에 대한 수요가 높아지고 있습니다.
치료 계획에 인공지능을 접목하고, 혈액뇌장벽을 통과하는 약물을 개발하며, 최소 침습 수술 기술이 발전함에 따라 치료 프로토콜이 재편되고 있습니다. 전 세계 의료 시스템은 전문 신경종양학 센터와 최첨단 의료기기에 대한 투자를 확대하고 있는 한편, 제약사들은 이 어려운 치료 분야에서 충족되지 않은 의료적 요구를 해결하기 위해 연구 개발 노력을 가속화하고 있습니다.
시장 역학
세계 뇌종양 치료 시장은 성장 궤도를 지속적으로 형성해 나가는 몇 가지 강력한 시장 성장 촉진요인에 힘입어 성장하고 있는 한편, 뚜렷한 시장 성장 억제요인에도 직면해 있어 이해관계자들에게 큰 기회를 제공합니다. 주요 시장 성장 요인으로는 모든 연령대에서 전 세계 뇌종양 발병률이 증가하고 있다는 점을 들 수 있습니다. 특히, 다양한 유형의 종양에 대한 감수성이 높은 고령 인구 증가와 더불어, 환자 및 의료진 사이에서 조기 진단과 치료 옵션에 대한 인식이 높아지고 있다는 점을 들 수 있습니다.
고해상도 MRI, PET 스캔, 분자진단 등 첨단 진단 기술을 통해 종양을 더 조기에 정확하게 발견할 수 있게 되었으며, 그 결과 치료 수요가 증가하고 있습니다. 표적 치료, 면역 치료, 유전자 프로파일링에 기반한 맞춤형 의료 등 새로운 치료 접근법의 급속한 발전으로 치료의 가능성이 확대되고 환자의 예후가 개선되고 있습니다. 그러나 뇌종양 치료에는 막대한 비용이 든다는 큰 제약이 있습니다. 대부분의 경우, 장기간에 걸친 다각적인 치료 접근법, 전문 장비, 장기 입원이 필요하며, 이는 환자와 의료 시스템 모두에게 경제적 장벽이 되고 있습니다.
혈액뇌장벽은 중대한 생물학적 과제이며, 약물 전달의 효과를 제한하고 치료 옵션을 좁히고 있습니다. 반면, 뇌종양의 복잡한 해부학적 위치는 외과적 시술을 본질적으로 위험하게 만들며, 경우에 따라서는 아예 불가능하게 만들기도 합니다. 새로운 치료법에 대한 엄격한 규제 승인 절차에 더해, 희귀 뇌종양 유형의 환자 수가 상대적으로 적은 점도 겹치면서 제약 기업들에게 또 다른 과제가 되고 있습니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안에 대한 매트릭스를 설명하고 있습니다.
- 또한 시장 성장 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략 등에 관한 중요한 분석도 제공합니다.
- 전 세계 뇌종양 치료 시장의 주요 기업 프로파일을 다양한 지표(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략 등)를 바탕으로 소개합니다.
- 본 보고서에서 다루고 있는 주요 기업으로는 F. Hoffmann-La Roche Ltd, Novartis AG, Merck & Co., Inc., Pfizer Inc., Bayer AG, Eisai Co., Ltd., Bristol-Myers Squibb Company, Amgen Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, y-Mabs Therapeutics Inc., Emcure Pharmaceuticals Ltd., NextSource Pharmaceuticals LLC, Daiichi Sankyo Co., Ltd. 등이 포함됩니다.
- 본 보고서의 인사이트를 바탕으로 마케팅 담당자와 기업 경영진은 향후 제품 출시, 제품 라인업 개편, 시장 확대 및 마케팅 전략에 관해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- ‘세계 뇌종양 치료 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 세계의 뇌종양 치료 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 뇌종양 치료 시장 : 치료법별(2021-2033년)
제5장 세계의 뇌종양 치료 시장 : 종양 유형별(2021-2033년)
제6장 세계의 뇌종양 치료 시장 : 약제 클래스별(2021-2033년)
제7장 세계의 뇌종양 치료 시장 : 연령층별(2021-2033년)
제8장 세계의 뇌종양 치료 시장 : 성별(2021-2033년)
제9장 세계의 뇌종양 치료 시장 : 최종 사용자별(2021-2033년)
제10장 세계의 뇌종양 치료 시장 : 유통 채널별(2021-2033년)
제11장 세계의 뇌종양 치료 시장 : 지역별(2021-2033년)
제12장 경쟁 구도
제13장 애널리스트의 제안
제14장 참고 문헌 및 분석 방법
KTH 26.06.19Brain Tumor Treatment Market is estimated to be valued at USD 2.58 Bn in 2026 and is expected to reach USD 5.05 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.1% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 2.58 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 10.10% | 2033 Value Projection: | USD 5.05 Bn |
The global brain tumor treatment market represents a critical segment within the broader oncology therapeutics landscape, addressing one of the most complex and challenging medical conditions affecting the central nervous system.
Brain tumors, characterized by abnormal cell growth within or around the brain tissue, encompass both primary tumors originating in the brain and secondary metastatic tumors spreading from other body parts. The treatment paradigm involves a multidisciplinary approach combining surgical interventions, radiation therapy, chemotherapy, targeted therapy, and emerging immunotherapy options, each tailored to specific tumor types, locations, and patient conditions.
The market's significance extends beyond traditional therapeutic modalities, incorporating advanced technologies such as stereotactic radiosurgery, tumor-treating fields, and personalized medicine approaches based on molecular profiling. Rising incidence rates of brain tumors globally, coupled with an aging population and improved diagnostic capabilities, have intensified the demand for effective treatment solutions.
The integration of artificial intelligence in treatment planning, development of blood-brain barrier penetrating drugs, and advancement in minimally invasive surgical techniques are reshaping treatment protocols. Healthcare systems worldwide are increasingly investing in specialized neuro-oncology centers and cutting-edge equipment, while pharmaceutical companies are accelerating research and development efforts to address unmet medical needs in this challenging therapeutic area.
Market Dynamics
The global brain tumor treatment market is propelled by several compelling drivers that continue to shape its growth trajectory, while simultaneously facing notable restraints and presenting significant opportunities for stakeholders. The primary market drivers include the escalating global incidence of brain tumors across all age groups, with particular emphasis on the growing geriatric population that exhibits higher susceptibility to various tumor types, alongside increasing awareness about early diagnosis and treatment options among patients and healthcare providers.
Advanced diagnostic technologies such as high-resolution MRI, PET scans, and molecular diagnostics are enabling earlier and more precise tumor detection, subsequently driving treatment demand. The rapid development of novel therapeutic approaches, including targeted therapies, immunotherapies, and personalized medicine based on genetic profiling, is expanding treatment possibilities and improving patient outcomes. However, the market faces substantial restraints including the extremely high costs associated with brain tumor treatments, which often require prolonged multi-modal therapy approaches, specialized equipment, and extended hospitalization periods that create financial barriers for patients and healthcare systems.
The blood-brain barrier presents a significant biological challenge, limiting drug delivery effectiveness and reducing therapeutic options, while the complex anatomical location of brain tumors makes surgical interventions inherently risky and sometimes impossible. Stringent regulatory approval processes for new therapies, coupled with the relatively small patient population for rare brain tumor types, create additional challenges for pharmaceutical companies.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global brain tumor treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- The key companies covered in this study include F. Hoffmann-La Roche Ltd, Novartis AG, Merck & Co., Inc., Pfizer Inc., Bayer AG, Eisai Co., Ltd., Bristol-Myers Squibb Company, Amgen Inc., GlaxoSmithKline plc, Johnson & Johnson, AstraZeneca PLC, y-Mabs Therapeutics Inc., Emcure Pharmaceuticals Ltd., NextSource Pharmaceuticals LLC, and Daiichi Sankyo Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global brain tumor treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global brain tumor treatment market
Market Segmentation
- Treatment Modality Insights (Revenue, USD Bn, 2021 - 2033)
- Chemotherapy (e.g., alkylating agents, cytotoxic drugs)
- Radiation Therapy (e.g., external beam radiation, stereotactic radiosurgery)
- Targeted Therapy (e.g., molecularly targeted small molecules)
- Immunotherapy (e.g., checkpoint inhibitors, CAR"'T therapies)
- Other Therapies (e.g., tumor"'treating fields, gene therapy, combination modalities)
- Tumor Type Insights (Revenue, USD Bn, 2021 - 2033)
- Primary Brain Tumors (e.g., glioblastoma, astrocytoma)
- Metastatic/Secondary Brain Tumors
- Meningioma
- Pituitary Tumors
- Other Tumor Types (e.g., oligodendroglioma, ependymoma)
- Drug Class Insights (Revenue, USD Bn, 2021 - 2033)
- Alkylating Agents
- Antimetabolites
- Monoclonal Antibodies
- Small"'Molecule Inhibitors
- Other Drug Classes (e.g., proteasome inhibitors, epigenetic modulators)
- Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- Pediatric
- Adult
- Geriatric
- Gender Insights (Revenue, USD Bn, 2021 - 2033)
- Male
- Female
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals and Integrated Cancer Centers
- Ambulatory Surgical/Outpatient Centers
- Specialty Clinics (neuro"'oncology clinics)
- Home Care/Remote Care Settings (where applicable)
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Mallinckrodt Pharmaceuticals plc
- Sun Pharmaceutical Industries Ltd.
- Johnson and Johnson
- Viatris Inc.
- Hikma Pharmaceuticals plc
- Aurobindo Pharma Ltd.
- Endo International plc
- Mylan"¯N.V. (now Viatris)
- Merck"¯KGaA
- Bristol"'Myers Squibb Company
- Grunenthal GmbH
- Sanofi S.A.
- AbbVie Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Brain Tumor Treatment Market, By Treatment Modality
- Global Brain Tumor Treatment Market, By Tumor Type
- Global Brain Tumor Treatment Market, By Drug Class
- Global Brain Tumor Treatment Market, By Age Group
- Global Brain Tumor Treatment Market, By Gender
- Global Brain Tumor Treatment Market, By End User
- Global Brain Tumor Treatment Market, By Distribution Channel
- Global Brain Tumor Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Brain Tumor Treatment Market, By Treatment Modality, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Chemotherapy (e.g., alkylating agents, cytotoxic drugs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Radiation Therapy (e.g., external beam radiation, stereotactic radiosurgery)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Targeted Therapy (e.g., molecularly targeted small molecules)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Immunotherapy (e.g., checkpoint inhibitors, CAR"'T therapies)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Therapies (e.g., tumor"'treating fields, gene therapy, combination modalities)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Brain Tumor Treatment Market, By Tumor Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Primary Brain Tumors (e.g., glioblastoma, astrocytoma)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Metastatic/Secondary Brain Tumors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Meningioma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Pituitary Tumors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Tumor Types (e.g., oligodendroglioma, ependymoma)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Brain Tumor Treatment Market, By Drug Class, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Alkylating Agents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Antimetabolites
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Monoclonal Antibodies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Small"'Molecule Inhibitors
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Other Drug Classes (e.g., proteasome inhibitors, epigenetic modulators)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Brain Tumor Treatment Market, By Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Brain Tumor Treatment Market, By Gender, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Brain Tumor Treatment Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals and Integrated Cancer Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ambulatory Surgical/Outpatient Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Specialty Clinics (neuro"'oncology clinics)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Home Care/Remote Care Settings (where applicable)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Brain Tumor Treatment Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
11. Global Brain Tumor Treatment Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Treatment Modality, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Tumor Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Treatment Modality, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Tumor Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Treatment Modality, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Tumor Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Treatment Modality, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Tumor Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Treatment Modality, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Tumor Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Treatment Modality, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Tumor Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Drug Class, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
12. Competitive Landscape
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mallinckrodt Pharmaceuticals plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson and Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Viatris Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hikma Pharmaceuticals plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aurobindo Pharma Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Endo International plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mylan"¯N.V. (now Viatris)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck"¯KGaA
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol"'Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Grunenthal GmbH
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
13. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
14. References and Research Methodology
- References
- Research Methodology
- About us
